Skip to main content
Download PDF

Correction: Triple MAPK inhibition salvaged a relapsed post-BCMA CAR-T cell therapy multiple myeloma patient with a BRAF V600E subclonal mutation

Journal of Hematology & Oncology volume 16, Article number: 52 (2023) Cite this article

The Original Article was published on 17 August 2022

Correction : Journal of Hematology & Oncology (2022) 15:109 https://doi.org/10.1186/s13045-022-01330-3


The authors of the original article [1] mistakenly omitted a Funding source which is stated ahead: Alessandro Lagana was supported by the ASH Bridge Grant Award.

Reference

  1. Elnaggar M, et al. Triple MAPK inhibition salvaged a relapsed post-BCMA CAR-T cell therapy multiple myeloma patient with a BRAF V600E subclonal mutation. J Hematol Oncol. 2022;15:109. https://doi.org/10.1186/s13045-022-01330-3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

    Muhammad Elnaggar, Sarita Agte, Paula Restrepo, Meghana Ram, David Melnekoff, Christos Adamopoulos, Katerina Kappes, Violetta Leshchenko, Daniel Verina, Sundar Jagannath, Poulikos I. Poulikakos, Samir Parekh & Alessandro Laganà

  2. Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA

    Muhammad Elnaggar, Paula Restrepo, David Melnekoff, Christos Adamopoulos, Poulikos I. Poulikakos & Alessandro Laganà

  3. Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA

    David Melnekoff

  4. Travera, Medford, MA, USA

    Mark M. Stevens

  5. Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA

    Alessandro Laganà

Authors
  1. Muhammad Elnaggar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sarita Agte
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Paula Restrepo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Meghana Ram
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. David Melnekoff
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Christos Adamopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mark M. Stevens
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Katerina Kappes
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Violetta Leshchenko
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Daniel Verina
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Sundar Jagannath
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Poulikos I. Poulikakos
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Samir Parekh
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Alessandro Laganà
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alessandro Laganà.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Elnaggar, M., Agte, S., Restrepo, P. et al. Correction: Triple MAPK inhibition salvaged a relapsed post-BCMA CAR-T cell therapy multiple myeloma patient with a BRAF V600E subclonal mutation. J Hematol Oncol 16, 52 (2023). https://doi.org/10.1186/s13045-023-01449-x

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13045-023-01449-x

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us